BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1350 related articles for article (PubMed ID: 8968075)

  • 1. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy.
    Hakomori S
    Cancer Cells; 1991 Dec; 3(12):461-70. PubMed ID: 1820092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disialosyl galactosylgloboside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential.
    Satoh M; Handa K; Saito S; Tokuyama S; Ito A; Miyao N; Orikasa S; Hakomori S
    Cancer Res; 1996 Apr; 56(8):1932-8. PubMed ID: 8620516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B lymphocyte binding to E- and P-selectins is mediated through the de novo expression of carbohydrates on in vitro and in vivo activated human B cells.
    Postigo AA; Marazuela M; Sánchez-Madrid F; de Landázuri MO
    J Clin Invest; 1994 Oct; 94(4):1585-96. PubMed ID: 7523454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion.
    Tsuiji H; Takasaki S; Sakamoto M; Irimura T; Hirohashi S
    Glycobiology; 2003 Jul; 13(7):521-7. PubMed ID: 12672699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
    Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell clone ecology hypothesis and the cell fusion model of cancer progression and metastasis (II): three pathways for spontaneous cell-cell fusion and escape from the intercellular matrix.
    Parris G
    Med Hypotheses; 2006; 67(1):172-6. PubMed ID: 16516400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fibronectin interaction with cell surface and extracellular matrix is mediated by carbohydrate-to-carbohydrate interaction.
    Zheng M; Hakomori Si
    Arch Biochem Biophys; 2000 Feb; 374(1):93-9. PubMed ID: 10640401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion molecules in tumor metastasis.
    Zetter BR
    Semin Cancer Biol; 1993 Aug; 4(4):219-29. PubMed ID: 8400144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of integrins and other cell adhesion molecules in tumor progression and metastasis.
    Albelda SM
    Lab Invest; 1993 Jan; 68(1):4-17. PubMed ID: 8423675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
    Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
    Uekita T; Sakai R
    Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
    Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
    Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Integrins and integrin-associated molecules: targets for the development of antimetastatic therapies].
    Velasco-Velázquez MA; Molina-Guarneros JA; Mendoza-Patiño N; Sullivan López J; Mandoki JJ
    Rev Invest Clin; 1999; 51(3):183-93. PubMed ID: 10466009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor metastases and adhesion molecules carbohydrates and lectins].
    Nemoto Y; Irimura T
    Gan To Kagaku Ryoho; 1999 May; 26(6):849-56. PubMed ID: 10410158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell N-glycans in metastasis.
    Laidler P; Lityńska A
    Acta Biochim Pol; 1997; 44(2):343-57. PubMed ID: 9360725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell adhesive mechanisms and their relationship to metastasis.
    McCarthy JB; Skubitz AP; Iida J; Mooradian DL; Wilke MS; Furcht LT
    Semin Cancer Biol; 1991 Jun; 2(3):155-67. PubMed ID: 1912525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
    Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
    Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.